Kenneth Klinker, PharmD

Regional Medical Scientific Director
Merck & Co, Inc

Disclosure: Merck & Co, Inc (Employee)

Dr. Ken Klinker, PharmD is a Regional Medical Scientific Director within US Medical Affairs, Merck & Co, Inc. He has 20+ years of clinical pharmacy experience including 40+ publications focused on the impact of antimicrobial stewardship initiatives at a large academic medical center. In his current role, he serves as a therapeutic and disease area expert engaging in scientific exchange and research support with external scientific leaders and investigators in the medical and scientific community.

Poster(s):

103 - Empiric Antibiotic Susceptibility Using a Traditional vs. Syndromic Antibiogram-Implications for Antimicrobial Stewardship Programs
1450 - Frequency of Carbapenem-resistant Pseudomonas aeruginosa Among Respiratory Pathogens Impacts First-Line Beta-Lactam Susceptibility: Potential Role for Ceftolozane/Tazobactam (C/T) and/or Imipenem/Relebactam (I/R)